Inhibition of inducible nitric oxide synthase prevents graft injury after transplantation of livers from rats after cardiac death

Liver Transplantation

Volumn 16, Issue 11, 2010, Pages 1267-1277

  Shi, Yanjun ^a   Rehman, Hasibur ^a   Wright, Gary L ^a   Zhong, Zhi ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; INDUCIBLE NITRIC OXIDE SYNTHASE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRATE; NITRITE; REACTIVE NITROGEN SPECIES; STRESS ACTIVATED PROTEIN KINASE; UNIVERSITY OF WISCONSIN SOLUTION;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CLAMPING; APOPTOSIS; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME INHIBITION; ENZYME RELEASE; EXPLANT; GRAFT FAILURE; GRAFT NECROSIS; GRAFT SURVIVAL; HEART DEATH; LIVER GRAFT; LIVER TRANSPLANTATION; MALE; MOUSE; NONHUMAN; ORGAN DONOR; ORGAN PRESERVATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ALANINE TRANSAMINASE; ANIMALS; BILIRUBIN; DEATH; ENZYME INHIBITORS; GRAFT REJECTION; GRAFT SURVIVAL; IMINES; LIVER; LIVER TRANSPLANTATION; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; NECROSIS; NITRATES; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PEROXYNITROUS ACID; RATS; RATS, INBRED LEW; REACTIVE NITROGEN SPECIES; TYROSINE;

EID: 78349231319     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22148     Document Type: Article

References (70)

1. Friend PJ, Imber CJ., Current status of liver transplantation. Methods Mol Biol 2006; 333: 29 - 46.
2. Said A, Einstein M, Lucey MR., Liver transplantation: an update 2007. Curr Opin Gastroenterol 2007; 23: 292 - 298.
3. Alexander JW, Vaughn WK., The use of "marginal" donors for organ transplantation. Transplantation 1991; 51: 135 - 141.
4. Abt PL, Desai NM, Crawford MD, Forman LM, Markmann JW, Olthoff KM, et al. Survival following liver transplantation from non-heart-beating donors. Ann Surg 2004; 239: 87 - 92.
5. Reddy S, Zilvetti M, Brockmann J, McLaren A, Friend P., Liver transplantation from non-heart-beating donors: current status and future prospects. Liver Transpl 2004; 10: 1223 - 1232.
6. Abt PL, Fisher CA, Singhal AK., Donation after cardiac death in the US: history and use. J Am Coll Surg 2006; 203: 208 - 225.
7. Deshpande R, Heaton N., Can non-heart-beating donors replace cadaveric heart-beating liver donors? J Hepatol 2006; 45: 499 - 503.
8. Casavilla A, Ramirez C, Shapiro R, Nghiem D, Miracle K, Bronsther O, et al. Experience with liver and kidney allografts from non-heart-beating donors. Transplantation 1995; 59: 197 - 203.
9. D'Alessandro AM, Fernandez LA, Chin LT, Shames BD, Turgeon NA, Scott DL, et al. Donation after cardiac death: the University of Wisconsin experience. Ann Transplant 2004; 9: 68 - 71.
10. Miyagi S, Iwane T, Akamatsu Y, Nakamura A, Sato A, Satomi S., The significance of preserving the energy status and microcirculation in liver grafts from non-heart-beating donor. Cell Transplant 2008; 17: 173 - 178.
11. Yagi T, Sadamori H, Nakagawa H, Ishikawa T, Sasaki H, Ohta K, et al. Hepatropic soluble vitamin E derivative EPC-K1 prevents warm ischemia/reperfusion injury of non-heart-beating donor liver transplantation in pigs. Transplant Proc 1997; 29: 1390 - 1393.
12. Lauschke H, Kotting M, Akbar S, Minor T., Use of taurine as antioxidant in resuscitating livers from non-heart-beating donors by gaseous oxygen persufflation. J Invest Surg 2003; 16: 7 - 11.
13. Shah V, Kamath PS., Nitric oxide in liver transplantation: pathobiology and clinical implications. Liver Transpl 2003; 9: 1 - 11.
14. Anggard E., Nitric oxide: mediator, murderer, and medicine. Lancet 1994; 343: 1199 - 1206.
15. Chen T, Zamora R, Zuckerbraun B, Billiar TR., Role of nitric oxide in liver injury. Curr Mol Med 2003; 3: 519 - 526.
16. Isobe M, Katsuramaki T, Hirata K, Kimura H, Nagayama M, Matsuno T., Beneficial effects of inducible nitric oxide synthase inhibitor on reperfusion injury in the pig liver. Transplantation 1999; 68: 803 - 813.
17. Urakami H, Abe Y, Grisham MB., Role of reactive metabolites of oxygen and nitrogen in partial liver transplantation: lessons learned from reduced-size liver ischaemia and reperfusion injury. Clin Exp Pharmacol Physiol 2007; 34: 912 - 919.
18. He S, Rehman H, Wright GL, Zhong Z., Inhibition of inducible nitric oxide synthase prevents mitochondrial damage and improves survival of steatotic partial liver grafts. Transplantation 2010; 89: 291 - 298.
19. Nakamura A, Akamatsu Y, Miyagi S, Fukumori T, Sekiguchi S, Satomi S., A free radical scavenger, edaravone, prevents ischemia-reperfusion injury in liver grafts from non-heart-beating donors. Transplant Proc 2008; 40: 2171 - 2174.
20. Iwane T, Akamatsu Y, Narita T, Nakamura A, Satomi S., The effect of perfusion prior to cold preservation and addition of biliverdin on the liver graft from non-heart-beating donors. Transplant Proc 2006; 38: 3358 - 3361.
21. Stegemann J, Hirner A, Rauen U, Minor T., Use of a new modified HTK solution for machine preservation of marginal liver grafts. J Surg Res 2010; 160: 155 - 162.
22. Bessems M, Doorschodt BM, van Vliet AK, van Gulik TM., Improved rat liver preservation by hypothermic continuous machine perfusion using polysol, a new, enriched preservation solution. Liver Transpl 2005; 11: 539 - 546.
23. Lee CY, Jain S, Duncan HM, Zhang JX, Jones JW Jr, Southard JH, et al. Survival transplantation of preserved non-heart-beating donor rat livers: preservation by hypothermic machine perfusion. Transplantation 2003; 76: 1432 - 1436.
24. Lee CY, Zhang JX, Jones JW Jr, Southard JH, Clemens MG., Functional recovery of preserved livers following warm ischemia: improvement by machine perfusion preservation. Transplantation 2002; 74: 944 - 951.
25. Gao W, Lemasters JJ, Thurman RG., Development of a new method for hepatic rearterialization in rat orthotopic liver transplantation: reduction of liver injury and improvement of surgical outcome by arterialization. Transplantation 1993; 56: 19 - 24.
26. Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ, et al. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 1997; 272: 4959 - 4963.
27. Zhong Z, Theruvath TP, Currin RT, Waldmeier PC, Lemasters JJ,. NIM811, a mitochondrial permeability transition inhibitor, prevents mitochondrial depolarization in small-for-size rat liver grafts. Am J Transplant 2007; 7: 1103 - 1111.
28. Rehman H, Connor HD, Ramshesh VK, Theruvath TP, Mason RP, Wright GL, et al. Ischemic preconditioning prevents free radical production and mitochondrial depolarization in small-for-size rat liver grafts. Transplantation 2008; 85: 1322 - 1331.
29. Uehara T, Xi Peng X, Bennett B, Satoh Y, Friedman G, Currin R, et al. c-Jun N-terminal kinase mediates hepatic injury after rat liver transplantation. Transplantation 2004; 78: 324 - 332.
30. Otero A, Gomez-Gutierrez M, Suarez F, Arnal F, Fernández- García A, Aguirrezabalaga J, et al. Liver transplantation from Maastricht category 2 non-heart-beating donors. Transplantation 2003; 76: 1068 - 1073.
31. Schon MR, Kollmar O, Wolf S, Schrem H, Matthes M, Akkoc N, et al. Liver transplantation after organ preservation with normothermic extracorporeal perfusion. Ann Surg 2001; 233: 114 - 123.
32. Dutkowski P, Furrer K, Tian Y, Graf R, Clavien PA., Novel short-term hypothermic oxygenated perfusion (HOPE) system prevents injury in rat liver graft from non-heart beating donor. Ann Surg 2006; 244: 968 - 976.
33. Ikegami T, Nishizaki T, Hiroshige S, Ohta R, Yanaga K, Sugimachi K., Experimental study of a type 3 phosphodiesterase inhibitor on liver graft function. Br J Surg 2001; 88: 59 - 64.
34. Xu HS, Stevenson WC, Pruett TL, Jones RS., Donor lazaroid pretreatment improves viability of livers harvested from non-heart-beating rats. Am J Surg 1996; 171: 113 - 116.
35. Astarcioglu H, Karademir S, Unek T, Ozer E, Menekay S, Coker A, et al. Beneficial effects of pentoxifylline pretreatment in non-heart-beating donors in rats. Transplantation 2000; 69: 93 - 98.
36. Gu M, Takada Y, Fukunaga K, Ishiguro S, Taniguchi H, Seino K, et al. Pharmacologic graft protection without donor pretreatment in liver transplantation from non-heart-beating donors. Transplantation 2000; 70: 1021 - 1025.
37. Manika A, Trinh T, Lagace G, Dugas MA, Proulx F, Lepage G, et al. N-acetylcysteine in pig liver transplantation from non-heart-beating donors. Transplantation 1999; 68: 327 - 330.
38. Lanteri R, Acquaviva R, Di Giacomo C, Sorrenti V, Li Destri G, Santangelo M, et al. Rutin in rat liver ischemia/reperfusion injury: effect on DDAH/NOS pathway. Microsurgery 2007; 27: 245 - 251.
39. Yanagida H, Kaibori M, Yoshida H, Habara K, Yamada M, Kamiyama Y, et al. Hepatic ischemia/reperfusion upregulates the susceptibility of hepatocytes to confer the induction of inducible nitric oxide synthase gene expression. Shock 2006; 26: 162 - 168.
40. Koeppel TA, Mihaljevic N, Kraenzlin B, Loehr M, Jesenofsky R, Post S, et al. Enhanced iNOS gene expression in the steatotic rat liver after normothermic ischemia. Eur Surg Res 2007; 39: 303 - 311.
41. Miranda KM, Espey MG, Jourd'heuil D, Grisham MB, Fukuto JM, Feelisch M, et al. The chemical biology of nitric oxide. In:, Ignarro LJ, ed. Nitric Oxide: Biology and Pathobiology. San Diego, CA: Academic Press; 2000: 41 - 55.
42. Radi R, Denicola A, Alvarez B, Ferrer-Sueta G, Rubbo H,. The biological chemistry of peroxynitrite. In:, Ignarro LJ, ed. Nitric Oxide: Biology and Pathobiology. San Diego, CA: Academic Press; 2000: 57 - 82.
43. Poderoso JJ., The formation of peroxynitrite in the applied physiology of mitochondrial nitric oxide. Arch Biochem Biophys 2009; 484: 214 - 220.
44. Peluffo G, Radi R., Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc Res 2007; 75: 291 - 302.
45. Molin MS., Interactions of oxidants with vascular signaling systems. Arterioscler Thromb Vasc Biol 2000; 20: 1430 - 1442.
46. Theruvath TP, Zhong Z, Currin RT, Ramshesh VK, Lemasters JJ., Endothelial nitric oxide synthase protects transplanted mouse livers against storage/reperfusion injury: Role of vasodilatory and innate immunity pathways. Transplant Proc 2006; 38: 3351 - 3357.
47. Kaizu T, Ikeda A, Nakao A, Takahashi Y, Tsung A, Kohmoto J, et al. Donor graft adenoviral iNOS gene transfer ameliorates rat liver transplant preservation injury and improves survival. Hepatology 2006; 43: 464 - 473.
48. Lang JD Jr, Teng X, Chumley P, Crawford JH, Isbell TS, Chacko BK, et al. Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J Clin Invest 2007; 117: 2583 - 2591.
49. Xia ZY, Wang XY, Chen X, Xia Z., Effect of NO donor sodium nitroprusside on lipopolysaccharide induced acute lung injury in rats. Injury 2007; 38: 53 - 59.
50. Malhi H, Gores GJ., Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin Liver Dis 2008; 28: 360 - 369.
51. Rosette C, Karin M., Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 1996; 274: 1194 - 1197.
52. Bradham CA, Stachlewitz RF, Gao W, Qian T, Jayadev S, Jenkins G, et al. Reperfusion after liver transplantation in rats differentially activates the mitogen activated protein kinases. Hepatology 1997; 25: 1128 - 1135.
53. Kon K, Kim JS, Jaeschke H, Lemasters JJ,. Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes. Hepatology 2004; 40: 1170 - 1179.
54. Wang Y, Singh R, Lefkowitch JH, Rigoli RM, Czaja MJ., Tumor necrosis factor-induced toxic liver injury results from JNK2-dependent activation of caspase-8 and the mitochondrial death pathway. J Biol Chem 2006; 281: 15258 - 15267.
55. Gunawan BK, Liu ZX, Han D, Hanawa N, Gaarde WA, Kaplowitz N., c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity. Gastroenterology 2006; 131: 165 - 178.
56. Yang JI, Yoon JH, Myung SJ, Gwak GY, Kim W, Chung GE, et al. Bile acid-induced TGR5-dependent c-Jun-N terminal kinase activation leads to enhanced caspase 8 activation in hepatocytes. Biochem Biophys Res Commun 2007; 361: 156 - 161.
57. Dhanasekaran DN, Reddy EP., JNK signaling in apoptosis. Oncogene 2008; 27: 6245 - 6251.
58. Lei K, Davis RJ., JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci U S A 2003; 100: 2432 - 2437.
59. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, et al. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 2000; 288: 870 - 874.
60. Morgan MJ, Kim YS, Liu ZG., TNFalpha and reactive oxygen species in necrotic cell death. Cell Res 2008; 18: 343 - 349.
61. Zhong Z, Ramshesh VK, Rehman H, Currin RT, Sridharan V, Theruvath TP, et al. Activation of the oxygen-sensing signal cascade prevents mitochondrial injury after mouse liver ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 2008; 295: G823 - G832.
62. Theruvath TP, Snoddy MC, Zhong Z, Lemasters, JJ,. Mitochondrial permeability transition in liver ischemia and reperfusion: role of c-Jun N-terminal kinase 2. Transplantation 2008; 85: 1500 - 1504.
63. Theruvath, TP, Zhong Z, Currin RT, Pediaditakis P, Lemasters JJ,. Minocycline mitigates storage/reperfusion injury after rat liver transplantation through suppression of the mitochondrial permeability transition. Hepatology 2008; 47: 235 - 246.
64. Theruvath TP, Czerny C, Ramshesh VK, Zhong Z, Chavin KD, Lemasters JJ,. C-Jun N-terminal kinase 2 promotes graft injury via the mitochondrial permeability transition after mouse liver transplantation. Am J Transplant 2008; 8: 1819 - 1828.
65. Sinha-Hikim I, Braga M, Shen R, Sinha Hikim AP., Involvement of c-Jun NH2-terminal kinase and nitric oxide-mediated mitochondria-dependent intrinsic pathway signaling in cardiotoxin-induced muscle cell death: role of testosterone. Apoptosis 2007; 12: 1965 - 1978.
66. Chen CC, Tsai PC, Wei BL, Chiou WF., 8-Prenylkaempferol suppresses inducible nitric oxide synthase expression through interfering with JNK-mediated AP-1 pathway in murine macrophages. Eur J Pharmacol 2008; 590: 430 - 436.
67. Chan ED, Morris KR, Belisle JT, Hill P, Remigio LK, Brennan PJ, et al. Induction of inducible nitric oxide synthase-NO* by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-kappaB signaling pathways. Infect Immun 2001; 69: 2001 - 2010.
68. Chakravortty D, Kato Y, Sugiyama T, Koide N, Mu MM, Yoshida T, et al. Inhibition of caspase 3 abrogates lipopolysaccharide-induced nitric oxide production by preventing activation of NF-kappaB and c-Jun NH2-terminal kinase/stress-activated protein kinase in RAW 264.7 murine macrophage cells. Infect Immun 2001; 69: 1315 - 1321.
69. Zingarelli B, Hake PW, Yang Z, O'Connor M, Denenberg A, Wong HR., Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-kappaB and AP-1 activation and enhances myocardial damage. FASEB J 2002; 16: 327 - 342.
70. Natal C, Modol T, Oses-Prieto JA, Lopez-Moratalla N, Iraburu MJ, Lopez-Zabalza MJ., Specific protein nitration in nitric oxide-induced apoptosis of human monocytes. Apoptosis 2008; 13: 1356 - 1367.